tiprankstipranks
Marker Therapeutics Inc (MRKR)
NASDAQ:MRKR
Holding MRKR?
Track your performance easily

Marker Therapeutics (MRKR) Income Statement

502 Followers

Marker Therapeutics Income Statement

Last quarter (Q3 2024), Marker Therapeutics's total revenue was $1.93M, an increase of 152.54% from the same quarter last year. In Q3, Marker Therapeutics's net income was $-2.31M. See Marker Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 7.39M$ 3.31M$ 3.51M$ 1.24M$ 466.79K$ 231.19K
Cost of Revenue
------
Gross Profit
$ 5.40M$ 3.31M$ 3.51M$ 1.24M$ 466.79K$ 231.19K
Operating Expense
$ 12.28M$ 14.58M$ 19.79M$ 40.72M$ 29.35M$ 22.74M
Operating Income
$ -10.19M$ -14.58M$ -19.79M$ -39.48M$ -28.89M$ -22.74M
Net Non Operating Interest Income Expense
$ 564.60K$ 539.16K$ 248.06K$ 5.70K$ 148.74K$ 1.08M
Other Income Expense
--$ -232.97K-$ -31.00K$ -231.19K
Pretax Income
$ -9.63M$ -14.04M$ -19.78M$ -39.47M$ -29.17M$ -21.43M
Tax Provision
$ 3.67K$ 3.67K$ -28.00K$ -291.00K$ -118.00K$ -665.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -12.15M$ -8.24M$ -29.93M$ -41.88M$ -29.17M$ -21.43M
Basic EPS
$ -1.36$ -0.94$ -3.58$ -5.50$ -6.10-
Diluted EPS
$ -1.36$ -0.94$ -3.58$ -5.50$ -6.10$ -0.47
Basic Average Shares
$ 35.63M$ 8.81M$ 8.35M$ 7.65M$ 4.70M$ 45.59M
Diluted Average Shares
$ 35.48M$ 8.81M$ 8.35M$ 7.65M-$ 45.59M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 15.59M$ 14.58M$ 19.79M$ 40.72M$ 29.35M$ 22.74M
Net Income From Continuing And Discontinued Operation
$ -9.70M$ -8.24M$ -29.93M$ -41.88M$ -28.71M$ -21.43M
Normalized Income
$ -8.99M$ -11.09M-$ -39.76M--
Interest Expense
------
EBIT
$ -9.83M$ -14.58M$ -19.79M$ -39.48M$ -28.42M$ -21.43M
EBITDA
$ -9.83M$ -14.58M$ -19.79M$ -36.32M$ -27.34M$ -21.14M
Currency in USD

Marker Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis